Canadian Risk Assessment Finds GMO Salmon Susceptible to Disease

"'The modus operandi at FDA is to rubber stamp AquaBounty’s flawed and biased studies and then call its review process 'science-based,''' said Jaydee Hanson, Senior Policy Analyst at the Center for Food Safety. 'FDA's inadequate risk assessment is at odds with reality, with science and with the public, which has long called on the agency to put consumers' health and environmental safety ahead of the corporate interests of the biotechnology industry.'"